Stockscreener 앱 받기
15.67
1.36%
0.21
시간 외 거래:
15.86
0.19
+1.21%
전일 마감가:
$15.46
열려 있는:
$15.37
하루 거래량:
2.08M
Relative Volume:
1.44
시가총액:
$2.73B
수익:
-
순이익/손실:
$-382.71M
주가수익비율:
-5.9809
EPS:
-2.62
순현금흐름:
$-325.64M
1주 성능:
+1.75%
1개월 성능:
+5.24%
6개월 성능:
-13.85%
1년 성능:
-44.86%
1일 변동 폭
$15.22
$16.10
1주일 범위
$14.58
$16.10
52주 변동 폭
$12.72
$32.10
Immunovant Inc Stock (IMVT) Company Profile
명칭
Immunovant Inc
전화
917-580-3099
주소
320 WEST 37TH STREET, NEW YORK, NY
IMVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
15.67 | 2.69B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-03-03 | 개시 | Jefferies | Hold |
| 2025-01-03 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-10-09 | 재확인 | Oppenheimer | Outperform |
| 2024-03-28 | 개시 | Oppenheimer | Outperform |
| 2024-03-13 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | JP Morgan | Overweight |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-13 | 업그레이드 | UBS | Neutral → Buy |
| 2023-09-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | 개시 | BofA Securities | Buy |
| 2023-04-25 | 개시 | Citigroup | Buy |
| 2023-03-31 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Stifel | Buy |
| 2023-02-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-08 | 개시 | Wells Fargo | Equal Weight |
| 2021-08-03 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-06-01 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-10-12 | 개시 | Guggenheim | Buy |
| 2020-10-08 | 개시 | Stifel | Buy |
| 2020-10-02 | 개시 | Credit Suisse | Outperform |
| 2020-08-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-25 | 개시 | Raymond James | Outperform |
| 2020-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | SVB Leerink | Outperform |
모두보기
Immunovant Inc 주식(IMVT)의 최신 뉴스
Immunovant, Inc. (NASDAQ:IMVT) Receives $33.60 Consensus PT from Analysts - MarketBeat
Insider Sale: President & Immunovant CEO of $ROIV Sells 683,818 Shares - Quiver Quantitative
Aug Spikes: Is Immunovant Inc. a play on infrastructure spendingEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک
FOMO Trade: What are Immunovant Incs earnings expectations2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - khodrobank.com
Gap Down: Should value investors consider Immunovant IncJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Published on: 2025-09-19 07:03:28 - khodrobank.com
Trading Recap: Why is WANG LEE GROUP Inc stock going down2025 Fundamental Recap & Accurate Technical Buy Alerts - khodrobank.com
Sentiment Watch: What are analysts price targets for Immunovant IncJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Highs Report: How is Hoth Therapeutics Inc. managing supply chain issues2025 Market Trends & Daily Volume Surge Signals - khodrobank.com
IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA - GlobeNewswire
Published on: 2025-09-18 21:39:43 - خودرو بانک
Aug Outlook: Does Immunovant Inc. have pricing powerWeekly Stock Summary & Real-Time Market Sentiment Reports - خودرو بانک
CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - GlobeNewswire Inc.
Dow Update: What is Immunovant Inc.’s book value per share2025 Stock Rankings & Fast Entry High Yield Stock Tips - خودرو بانک
Investment Recap: What dividend growth rate does Immunovant Inc offer2025 Market WrapUp & Weekly High Return Forecasts - khodrobank.com
Earnings Update: Will Immunovant Inc. benefit from geopolitical trendsTrade Risk Assessment & Capital Efficiency Focused Strategies - خودرو بانک
Rate Cut: Will Immunovant Inc. benefit from geopolitical trends2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک
Earnings Update: What drives Immunovant Incs stock priceJuly 2025 Movers & Low Risk High Reward Trade Ideas - خودرو بانک
Buyback Watch: Will Immunovant Inc announce a stock splitMarket Activity Report & AI Enhanced Trade Execution Alerts - khodrobank.com
Surprises Report: Is Immunovant Inc affected by consumer sentiment2025 Key Lessons & High Accuracy Trade Signal Alerts - خودرو بانک
Profit Recap: Can Monro Inc. weather a recessionWeekly Market Report & Stepwise Swing Trade Plans - خودرو بانک
Immunovant, Inc. $IMVT Shares Bought by Woodline Partners LP - MarketBeat
Insiders At Immunovant Sold US$3.9m In Stock, Alluding To Potential Weakness - 富途牛牛
Adage Capital Partners GP L.L.C. Has $362,000 Position in Immunovant, Inc. $IMVT - MarketBeat
Immunovant Inc. stock prediction for this weekJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Technical analysis overview for Immunovant Inc. stock2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
Applying sector rotation models to Immunovant Inc.2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Order flow analysis tools used on Immunovant Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com
Why Immunovant Stock Blasted Higher Today - MSN
Immunovant, Inc. $IMVT is Two Seas Capital LP's 10th Largest Position - MarketBeat
IMMUNOVANT INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc.IMVT - Business Wire
Cubist Systematic Strategies LLC Purchases 47,322 Shares of Immunovant, Inc. $IMVT - MarketBeat
Roivant Sciences (ROIV) Is Up 9.4% After Positive Immunovant Data and Japan Orphan Drug NodWhat's Changed - Yahoo Finance
EFG Asset Management North America Corp. Has $2.23 Million Stock Holdings in Immunovant, Inc. $IMVT - MarketBeat
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Immunovant (IMVT) Highlights New Graves’ Disease Data Can Its Pipeline Deliver Sustainable Innovation? - Yahoo Finance
What data driven models say about Immunovant Inc.’s futureWall Street Watch & Low Drawdown Trading Strategies - Newser
Canada Pension Plan Investment Board Has $3.12 Million Position in Immunovant, Inc. $IMVT - MarketBeat
A Look at Immunovant's Valuation Following New Batoclimab Data Update for Graves' Disease - Yahoo Finance
Immunovant's (IMVT) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Immunovant, Inc. $IMVT Shares Acquired by Granahan Investment Management LLC - MarketBeat
Regression Model Predicts Rangebound Movement in Immunovant Inc.July 2025 News Drivers & Weekly Watchlist of Top Performers - beatles.ru
Immunovant Inc. Pullback Analyzed — Is It Time to Exit2025 EndofYear Setup & High Return Trade Opportunity Guides - beatles.ru
Immunovant (NASDAQ:IMVT) Shares Up 10%What's Next? - MarketBeat
LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN
Should you avoid Immunovant Inc. stock right nowJuly 2025 Selloffs & Daily Chart Pattern Signals - beatles.ru
Is Immunovant Inc. stock a good pick for beginners2025 Bull vs Bear & Real-Time Price Movement Reports - 뉴스영
Immunovant, Inc. $IMVT Shares Bought by ADAR1 Capital Management LLC - MarketBeat
Visual analytics tools that track Immunovant Inc. performanceMarket Risk Report & Short-Term High Return Ideas - Newser
Immunovant, Inc. $IMVT Holdings Lowered by Redmile Group LLC - MarketBeat
OMERS ADMINISTRATION Corp Takes $825,000 Position in Immunovant, Inc. $IMVT - MarketBeat
Immunovant Inc (IMVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):